SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model
Intrahepatic cholestasis is a kind of clinical syndrome along with hepatotoxicity which caused by intrahepatic and systemic accumulations of bile acid. There are several crucial generating factors of the pathogenesis of cholestasis, such as inflammation, dysregulation of bile acid transporters and o...
Main Authors: | Linxi Yu, Xiaoxin Liu, Zihang Yuan, Xiaojiaoyang Li, Hang Yang, Ziqiao Yuan, Lixin Sun, Luyong Zhang, Zhengzhou Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00256/full |
Similar Items
-
SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson's disease
by: Chih-Chang Chao, et al.
Published: (2022-12-01) -
SRT1720‐induced activation of SIRT1 alleviates vascular smooth muscle cell senescence through PKA‐dependent phosphorylation of AMPKα at Ser485
by: Jin Young Sung, et al.
Published: (2020-07-01) -
Pterostilbene Alleviates Cholestasis by Promoting SIRT1 Activity in Hepatocytes and Macrophages
by: Chuanrui Ma, et al.
Published: (2021-11-01) -
Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice
by: Shizhang Wei, et al.
Published: (2023-05-01) -
Possible Protective Effect of Low Dose of Papaverine on ANIT Induce Cholestasis in Rat
by: Doaa Adnan Atshan, et al.
Published: (2023-11-01)